Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Safety evaluation of the food enzyme α-amylase from the genetically modified Bacillus licheniformis strain DP-Dzb52

EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP) et al. EFSA J. .

Abstract

The food enzyme α-amylase (1,4-α-d-glucan glucanohydrolase; EC 3.2.1.1) is produced with the genetically modified Bacillus licheniformis strain DP-Dzb52 by Danisco US Inc. The production strain contains multiple copies of an antimicrobial resistance gene. However, based on the absence of viable cells and DNA from the production organism in the food enzyme, this is not considered to be a risk. The α-amylase is intended to be used in starch processing for the production of glucose syrups, brewing processes and distilled alcohol production. Since residual amounts of the food enzyme are removed by the purification steps applied during the production of glucose syrups and distillation, no dietary exposure was calculated. Based on the maximum use levels recommended for the brewing processes and individual data from the EFSA Comprehensive European Food Consumption Database, dietary exposure to the enzyme-total organic solids (TOS) was estimated to be up to 0.145 TOS/kg body weight per day in European populations. The toxicity studies were carried out with another α-amylase from B. licheniformis strain DP-Dzb54, considered by the Panel as a suitable substitute. Toxicological tests indicated that there was no concern with respect to genotoxicity or systemic toxicity. A no observed adverse effect level was identified in rats which, compared with the dietary exposure, results in a margin of exposure of at least 750. A search for similarity of the amino acid sequence to known allergens was made and one match was found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions can be excluded in distilled alcohol production and is considered low when the enzyme is used in starch processing and brewing. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.

Keywords: 1,4‐α‐d‐glucan glucanohydrolase; Bacillus licheniformis; EC 3.2.1.1; food enzyme; genetically modified microorganism; glycogenase; α‐amylase.

PubMed Disclaimer

References

    1. Armentia A, Dias‐Perales A, Castrodeza J, Dueñas‐Laita A, Palacin A and Fernándes S, 2009. Why can patients with baker's asthma tolerate wheat flour ingestion? Is wheat pollen allergy relevant? Allergologia et Immunopathologia, 37, 203–204. 10.1016/j.aller.2009.05.001 - DOI - PubMed
    1. Baur X and Czuppon AB, 1995. Allergic reaction after eating α‐amylase (Asp o 2)‐containing bred. A case report. Allergy, 50, 85–87. 10.1111/j.1398-9995.1995.tb02487.x - DOI - PubMed
    1. Brisman J, 2002. Baker's asthma. Occupational and Environmental Medicine, 59, 498–502; quiz 502, 426. - PMC - PubMed
    1. Brisman J and Belin L, 1991. Clinical and immunological responses to occupational exposure to α‐amylase in the baking industry. British Journal of Industrial Medicine, 48, 604–608. - PMC - PubMed
    1. Cullinan P, Cook A, Jones M, Cannon J, Fitzgerald B and Newman Taylor AJ, 1997. Clinical responses to ingested fungal α‐amylase and hemicellulase in persons sensitized to Aspergillus fumigatus? Allergy, 52, 346–349. 10.1111/j.1398-9995.1997.tb01003.x - DOI - PubMed